Figure 3. A photomicrograph of the immunohistochemical expression of IL23p19 in a) The control group showing very minimal expression; b) UC patients before treatment showing extensive expression; c) Metformin treated group with moderate expression; d) I3C treated group with moderate expression; e) Metformin/I3C treated group with mild expression of IL23p19 (Anti-IL-23 p19 X400)

From

Effect of Indole-3-carbinol and/or Metformin on Female Patients with Ulcerative Colitis (Premalignant Condition): Role of Oxidative Stress, Apoptosis and Proinflammatory Cytokines

Ahmed M. Kabel, Mohamed S. Omar, Sultan N. Alotaibi, Mohammed H. Baali

• Previous
• Figure 3 of 3  (Figures index)